Skip to Main Content
Our specialists
Find specialists supported by world-renowned researchers & educators.
>
See our specialists
Where to find us
See a map of Clinic Locations
>
Clinical Locations
Referrals
Information for referring doctors
>
Refer a patient

Clinical Programs

At Yale Urology, our surgeons care for patients with a wide variety of conditions, from the most common to the most complicated urologic problems. We offer our patients comprehensive programs in a broad range of subspecialties including oncology, infertility, pediatrics, neuro-urology and female urology, the management of stone disease and minimally invasive surgery. The department makes substantial contributions to research and education in urology, ensuring that patients have access to cutting-edge methodologies and the latest clinical findings.

Our urologists have developed clinical expertise in one or more sub-specialties to provide comprehensive treatment of the most complex urological problems which can include:

  • Urologic oncology, including cancer of the bladder, prostate, testis, kidney, and penis
  • Kidney stone prevention and treatment, including extracorporeal shock wave lithotripsy (ESWL), nutrition counseling and medical management
  • Neuro and female urology, providing care for voiding dysfunction, incontinence, female urologic problems, and urinary tract difficulties related to neurologic diseases
  • Treatment of male infertility, addressed with microsurgical and minimally-invasive techniques for conditions such as varicoceles, obstruction of the vas deferens or epididymis, and dysfunction of sperm maturation

Our urologists use laparoscopic techniques, decreasing the usual lengths of stay associated with traditional surgery.

Programs & Specialties

Fact Sheets

News from Yale Medicine

In the News

Clinical Trials

Prostate Cancer, Bladder Cancer

A Phase 1, First-in-Human, Dose-Escalation and Expansion Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

AgeANY
GenderANY
Date20 December
Prostate Cancer

A Phase 1/2 Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer

AgeANY
GenderANY
Date9 September
Bladder Cancer

A Phase 2, Randomized, Multi-center, Open Label Trial to Evaluate the Safety and Efficacy of Intravesical Nadofaragene Firadenovec Alone or in Combination with Chemotherapy or Immunotherapy in Participants with High-grade Bacillus Calmette-Guerin Therapy (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)

AgeANY
GenderANY
Date24 February
Children's Health, Kidney & Urinary Tract

Comparison of smart bedwetting alarm vs standard bedwetting alarm

Age6-21 years
GenderNon Binary
Date2 February